Literature DB >> 22416177

15-PGDH is reduced and induces apoptosis and cell cycle arrest in gastric carcinoma.

Li-Hong Lou1, Da-Dao Jing, Yue-Xing Lai, Ying-Ying Lu, Ji-Kun Li, Kai Wu.   

Abstract

AIM: To investigate the expression of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in human gastric cancer and it's mechanism in apoptosis and cell cycle arrest.
METHODS: Expression of 15-PGDH mRNA and protein was examined by immunohistochemistry, immunocytochemistry, reverse transcriptase polymerase chain reaction (RT-PCR) and Western blotting in tissue from human gastric cancer, gastric precancerous state (gastric polyps and atrophic gastritis), normal stomach, and gastric cancer cell lines. The relationship between gastric cancer, gastric precancerous state and 15-PGDH expression was determined. The association between expression of 15-PGDH and various clinicopathological parameters in gastric cancer was evaluated. Human gastric cancer cell line SGC-7901 was transfected with 15-PGDH expression plasmids. The effect of 15-PGDH on the cell cycle was examined by flow cytometry. The effect of 15-PGDH on apoptosis was examined by transmission electron microscopy, flow cytometry and transferase mediated nick end labeling (TUNEL) assay. Expression of cell cycle (p21, p27, p16 and p53) and apoptosis (Survivin, BCL-2, BCL-X(L), BAK and BAX) genes was analyzed by RT-PCR.
RESULTS: Expression of 15-PGDH mRNA and protein in human gastric cancer tissues was significantly lower than in normal gastric tissues (P < 0.01). Expression in human gastric cancer cell lines MKN-28 and MKN-45 was reduced, and absent in SGC-7901 cells (P < 0.05). Reduction of 15-PGDH expression was also found in precancerous tissues, such as gastric polyps and atrophic gastritis (P < 0.01). There was a significant difference in expression of 15-PGDH among various gastric cancer pathological types (P < 0.05), with or without distant metastasis (P < 0.05) and different TNM stage (P < 0.01). Flow cytometry demonstrated a significant increase in apoptotic cells in SGC-7901 cells transfected with pcDNA3/15-PGDH plasmid for 24 h and 48 h (P < 0.01), and an increased fraction of sub-G1 phase after transfection (P < 0.05). TUNEL assay showed an increased apoptotic index in cells overexpressing 15-PGDH (P < 0.01). After transfection, expression of proapoptotic genes, such as BAK (P < 0.05), BAX and p53 (P < 0.01), was increased. Expression of antiapoptotic genes was decreased, such as Survivin, BCL-2 and BCL-X(L) (P < 0.01). Expression of cyclin-dependent kinase inhibitors p21 and p16 (P < 0.01) was significantly upregulated in cells overexpressing 15-PGDH.
CONCLUSION: Reduction of 15-PGDH is associated with carcinogenesis and development of gastric carcinoma. 15-PGDH induces apoptosis and cell cycle arrest in SGC-7901 cells.

Entities:  

Keywords:  15-hydroxyprostaglandin dehydrogenase; Apoptosis; Cell cycle arrest; Gastric carcinoma; Tumor growth

Mesh:

Substances:

Year:  2012        PMID: 22416177      PMCID: PMC3296976          DOI: 10.3748/wjg.v18.i10.1028

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  37 in total

1.  Expression, deletion [was deleton] and mutation of p16 gene in human gastric cancer.

Authors:  X S He; Q Su; Z C Chen; X T He; Z F Long; H Ling; L R Zhang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

2.  15-Hydroxyprostaglandin dehydrogenase is a tumor suppressor of human gastric cancer.

Authors:  Zhenxiong Liu; Xin Wang; Yuanyuan Lu; Rui Du; Guanhong Luo; Jun Wang; Huihong Zhai; Faming Zhang; Qinsheng Wen; Kaichun Wu; Daiming Fan
Journal:  Cancer Biol Ther       Date:  2010-10-15       Impact factor: 4.742

3.  Interleukin-4 up-regulates 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in human lung cancer cells.

Authors:  Xiuling Chi; Hsin-Hsiung Tai
Journal:  Exp Cell Res       Date:  2010-08-15       Impact factor: 3.905

4.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

Authors:  H Toyoshima; T Hunter
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

5.  Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair.

Authors:  R Li; S Waga; G J Hannon; D Beach; B Stillman
Journal:  Nature       Date:  1994-10-06       Impact factor: 49.962

6.  Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis.

Authors:  Nathan R Wall; Daniel S O'Connor; Janet Plescia; Yves Pommier; Dario C Altieri
Journal:  Cancer Res       Date:  2003-01-01       Impact factor: 12.701

7.  Comparison of substrate specificities of the human placental NAD- and NADP-linked 15-hydroxyprostaglandin dehydrogenases.

Authors:  J Jarabak; J Fried
Journal:  Prostaglandins       Date:  1979-08

8.  Synergistic induction of the nicotinamide adenine dinucleotide-linked 15-hydroxyprostaglandin dehydrogenase by an androgen and interleukin-6 or forskolin in human prostate cancer cells.

Authors:  Min Tong; Hsin-Hsiung Tai
Journal:  Endocrinology       Date:  2004-01-28       Impact factor: 4.736

9.  p21-containing cyclin kinases exist in both active and inactive states.

Authors:  H Zhang; G J Hannon; D Beach
Journal:  Genes Dev       Date:  1994-08-01       Impact factor: 11.361

10.  Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells.

Authors:  Zhi-Min Liu; George G Chen; Enders K W Ng; Wai-Keung Leung; Joseph J Y Sung; S C Sydney Chung
Journal:  Oncogene       Date:  2004-01-15       Impact factor: 9.867

View more
  8 in total

1.  Inverse expression of prostaglandin E2-related enzymes highlights differences between diverticulitis and inflammatory bowel disease.

Authors:  Liying Dai; Denis W King; D Shevy Perera; David Z Lubowski; Elizabeth Burcher; Lu Liu
Journal:  Dig Dis Sci       Date:  2015-02-11       Impact factor: 3.199

2.  Celecoxib enhances the efficacy of 15-hydroxyprostaglandin dehydrogenase gene therapy in treating murine breast cancer.

Authors:  Binglan Zhang; Xuelei Ma; Zhimian Li; Xiang Gao; Fengtian Wang; Lei Liu; Guobo Shen; Yaxiong Sang; Minmin Li; Yuli Li; Jingyi Zhao; Yuquan Wei
Journal:  J Cancer Res Clin Oncol       Date:  2013-02-06       Impact factor: 4.553

3.  15-hydroxyprostaglandin dehydrogenase is upregulated by hydroxychloroquine in rheumatoid arthritis fibroblast-like synoviocytes.

Authors:  Hak-Jae Kim; Sora Lee; Haw-Yong Lee; Hansol Won; Sung-Hae Chang; Seong-Su Nah
Journal:  Mol Med Rep       Date:  2015-06-15       Impact factor: 2.952

4.  Cyclooxygenase and prostaglandin in cancer.

Authors:  Jong-Woo Kim
Journal:  J Korean Soc Coloproctol       Date:  2012-10-31

5.  Effect of 15-hydroxyprostaglandin dehydrogenase gene on the proliferation of gastric cancer cell murine forestomach carcinoma.

Authors:  Lihua Li; Fu Yang; Xiaojie Wang; Jing Hu; Libo Yang; Chunming Tang; Yunhua Wu; Kun Miao; Rui Liu; Tao Shou
Journal:  Exp Ther Med       Date:  2013-11-12       Impact factor: 2.447

6.  Relationship between 15-hydroxyprostaglandin dehydrogenase and gastric adenocarcinoma.

Authors:  Jae Hyun Kang; Sang Hyun Kang; Sang Hyuk Seo; Jae Ho Shin; Min Sung An; Tae Kwun Ha; Ki Beom Bae; Tae Hyun Kim; Chang Soo Choi; Sang Hoon Oh; Mi Seon Kang; Kwang Hee Kim
Journal:  Ann Surg Treat Res       Date:  2014-05-23       Impact factor: 1.859

7.  Expression of 15-hydroxyprostaglandin dehydrogenase and cyclooxygenase-2 in non-small cell lung cancer: Correlations with angiogenesis and prognosis.

Authors:  Ying Li; Suli Li; Dan Sun; Linlin Song; Xinmin Liu
Journal:  Oncol Lett       Date:  2014-07-22       Impact factor: 2.967

8.  Prostaglandin E2 Pathway Is Dysregulated in Gastric Adenocarcinoma in a Caucasian Population.

Authors:  Catarina Lopes; Carina Pereira; Mónica Farinha; Rui Medeiros; Mário Dinis-Ribeiro
Journal:  Int J Mol Sci       Date:  2020-10-16       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.